PMC7547347_01
This figure shows the right upper eyelid swelling and ptosis with a palpable firm mass 20 mm in diameter.
CRIOPM2020-8827074.001.jpg
PMC7547347_01_CRIOPM2020-8827074.001.jpg
fig1
Physical examination showed the right upper eyelid swelling and ptosis with a nontender palpable firm mass 20 mm in diameter (Figure 1).
(a) Computed tomography (CT) axial view. (b) Computed tomography (CT) coronal view. (a, b) An infiltrative mass at the right superolateral orbital involving the lacrimal gland and upper eyelid.
CRIOPM2020-8827074.002.jpg
PMC7547347_01_CRIOPM2020-8827074.002.jpg
fig2
Computed tomography (CT) showed an infiltrative mass at the right superolateral orbital involving the lacrimal gland and upper eyelid (Figures 2(a) and 2(b)).
A mass involving the septum and orbital fat with multiple loculated abscesses.
CRIOPM2020-8827074.003.jpg
PMC7547347_01_CRIOPM2020-8827074.003.jpg
fig3
A mass involving the septum and orbital fat with multiple loculated abscess was observed intraoperatively (Figure 3).
(a) Histopathologic section shows fungal hyphae in granulomatous inflammation background (H&E 400x). (b) Periodic acid-Schiff (PAS) (600x). (c) Grocott methenamine silver (GMS) staining (600x). (b, c) Broad nonseptate and septate hyphae with the right angle branching on PAS and GMS.
CRIOPM2020-8827074.004.jpg
PMC7547347_01_CRIOPM2020-8827074.004.jpg
fig4
Histopathology demonstrated granulomatous inflammation (Figure 4(a)) with broad nonseptate and sparsely septate hyphae with the right angle branching on periodic acid-Schiff (PAS) (Figure 4(b)) and Grocott methenamine silver (GMS) staining (Figure 4(c)) with no vascular invasion.
The patient at 3-month follow-up.
CRIOPM2020-8827074.005.jpg
PMC7547347_01_CRIOPM2020-8827074.005.jpg
fig5
At 3-month follow-up, there was complete resolution of all symptoms and signs (Figure 5).